Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Study of Cryoablation and Nirogacestat for Desmoid Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cryoablation in combination with nirogacestat for desmoid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cryoablation
  • Nirogacestat (nirogacestat)

Snippet

Sponsor: Nam Bui | Conditions: Desmoid Tumor | Phase 2 | Status: RECRUITING